Ohcanbohtosat - Keyue Ding
- Čájehuvvo 1 - 20 / 41
- Sirdás čuovvovaš siidui
-
1
-
2
LDA—a java-based linkage disequilibrium analyzer Dahkki Keyue Ding, Kaixin Zhou, Fuchu He, Yan Shen
Almmustuhtton 2003Artigo -
3
-
4
Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21 Dahkki Paul Wheatley‐Price, Keyue Ding, Lesley Seymour, Gary M. Clark, Frances A. Shepherd
Almmustuhtton 2008Artigo -
5
-
6
-
7
Prognostic and Predictive Role of the VeriStrat Plasma Test in Patients with Advanced Non–Small-Cell Lung Cancer Treated with Erlotinib or Placebo in the NCIC Clinical Trials Group... Dahkki David P. Carbone, Keyue Ding, Heinrich Röder, Julia Grigorieva, Joanna Roder, Ming‐Sound Tsao, Lesley Seymour, Frances A. Shepherd
Almmustuhtton 2012Artigo -
8
Age and Comorbidity As Independent Prognostic Factors in the Treatment of Non–Small-Cell Lung Cancer: A Review of National Cancer Institute of Canada Clinical Trials Group Trials Dahkki Timothy R. Asmis, Keyue Ding, Lesley Seymour, Frances A. Shepherd, Natasha B. Leighl, Tim Winton, Marlo Whitehead, Johanna N. Spaans, Barbara Graham, Glenwood Goss
Almmustuhtton 2007Revisão -
9
Adjuvant Vinorelbine and Cisplatin in Elderly Patients: National Cancer Institute of Canada and Intergroup Study JBR.10 Dahkki Carmela Pepe, Baktiar Hasan, Timothy Winton, Lesley Seymour, Barbara Graham, Robert B. Livingston, David H. Johnson, James R. Rigas, Keyue Ding, Frances A. Shepherd
Almmustuhtton 2007Artigo -
10
Nadir Testosterone Within First Year of Androgen-Deprivation Therapy (ADT) Predicts for Time to Castration-Resistant Progression: A Secondary Analysis of the PR-7 Trial of Intermit... Dahkki Laurence Klotz, Chris J. O’Callaghan, Keyue Ding, Paul Toren, David P. Dearnaley, Celestia S. Higano, Eric M. Horwitz, Shawn Malone, Larry Goldenberg, Mary Gospodarowicz, Juanita Crook
Almmustuhtton 2015Artigo -
11
Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non–Small-Cell Lung Cancer: Results From a Randomized Trial, JBR.10 Dahkki Andrea Bezjak, Christopher W. Lee, Keyue Ding, Michael Brundage, Timothy Winton, Barbara Graham, Marlo Whitehead, David H. Johnson, Robert B. Livingston, Lesley Seymour, Frances A. Shepherd
Almmustuhtton 2008Artigo -
12
Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institu... Dahkki Tara Baetz, Andrew R. Belch, Stephen Couban, Kevin Imrie, J. Yau, Robert E. Myers, Keyue Ding, Narinder Paul, L. E. Shepherd, José Iglesias, Ralph M. Meyer, Michael Crump
Almmustuhtton 2003Artigo -
13
Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation Dahkki Jean-Yves Douillard, Hélène Tribodet, D. Aubert, Frances A. Shepherd, Rafael Rosell, Keyue Ding, Anne-Sophie Veillard, Lesley Seymour, Thierry Le Chevalier, Stephen Spiro, Richard Stephens, Jean‐Pierre Pignon
Almmustuhtton 2010Artigo -
14
Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer Dahkki Martin Früh, Estelle Rolland, Jean‐Pierre Pignon, Lesley Seymour, Keyue Ding, Hélène Tribodet, Timothy Winton, Thierry Le Chevalier, Giorgio V. Scagliotti, Jean-Yves Douillard, Stephen Spiro, Frances A. Shepherd
Almmustuhtton 2008Artigo -
15
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor... Dahkki Alona Zer, Keyue Ding, Siow Ming Lee, Glenwood Goss, Lesley Seymour, Peter Ellis, Allan Hackshaw, Penelope A. Bradbury, Lei Han, Christopher J. O’Callaghan, Ming‐Sound Tsao, Frances A. Shepherd
Almmustuhtton 2015Artigo -
16
Prognostic and Predictive Value of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutation Status and Gene Copy Number for Adjuvant Chemotherapy in Non-small Cell Lung Can... Dahkki Ming‐Sound Tsao, Akira Sakurada, Keyue Ding, Sarit Aviel‐Ronen, Olga Ludkovski, Ni Liu, Aurélie Le Maître, David R. Gandara, David H. Johnson, James R. Rigas, Lesley Seymour, Frances A. Shepherd
Almmustuhtton 2010Artigo -
17
Class III β-Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non–Small Cell Lung Cancer: Analysis of NCIC JBR.10 Dahkki P. Sève, Raymond Lai, Keyue Ding, Timothy Winton, Charles Butts, John R. Mackey, Charles Dumontet, Laith Dabbagh, Sarit Aviel‐Ronen, Lesley Seymour, Marlo Whitehead, Ming‐Sound Tsao, Frances A. Shepherd, Tony Reiman
Almmustuhtton 2007Artigo -
18
Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Cl... Dahkki Ralph M. Meyer, Mary Gospodarowicz, Joseph M. Connors, R. Pearcey, Andrea Bezjak, Woodrow Wells, Bruce F. Burns, Jane N. Winter, Sandra J. Horning, A. Rashid Dar, Marina Djurfeldt, Keyue Ding, Lois E. Shepherd
Almmustuhtton 2005Artigo -
19
Association between genetic variation of <i>CACNA1H</i> and childhood absence epilepsy Dahkki Yucai Chen, Jianjun Lu, Hong Pan, Yuehua Zhang, Husheng Wu, Keming Xu, Xiaoyan Liu, Yuwu Jiang, Xinhua Bao, Zhijian Yao, Keyue Ding, Wilson H.Y. Lo, Boqin Qiang, Piu Chan, Yan Shen, Xiru Wu
Almmustuhtton 2003Artigo -
20
Complement Receptor 1 Gene Variants Are Associated with Erythrocyte Sedimentation Rate Dahkki Iftikhar J. Kullo, Keyue Ding, Khader Shameer, Catherine A. McCarty, Gail P. Jarvik, Joshua C. Denny, Marylyn D. Ritchie, Zi Ye, David R. Crosslin, Rex L. Chisholm, Teri A. Manolio, Christopher G. Chute
Almmustuhtton 2011Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Oncology
Cancer
Chemotherapy
Biology
Lung cancer
Confidence interval
Gene
Hazard ratio
Genetics
Surgery
Cisplatin
Randomized controlled trial
Vinorelbine
Epidermal growth factor receptor
Cancer research
Paleontology
Pathology
Radiation therapy
Stage (stratigraphy)
Adjuvant
Alternative medicine
Clinical trial
Gastroenterology
Placebo
Genotype
Single-nucleotide polymorphism
Androgen deprivation therapy
Erlotinib